![Didier Piccino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Didier Piccino
Direttore/Membro del Consiglio presso iQera SASU
Provenienza dei contatti di primo grado di Didier Piccino
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Seventure Partners SA
![]() Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.
44
| Subsidiary | Investment Managers | 44 |
iQera SASU
![]() iQera SASU Packaged SoftwareTechnology Services iQera SASU engages in the provision of debt collection solutions. Its products include auditing and decisional software systems. The firm offers account management, debt buying, legal mediation, and outsourcing services. The company was founded by Jean François Bensahel in 2001 and is headquartered in Paris, France.
6
| Subsidiary | Packaged Software | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Didier Piccino tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cerecin, Inc.
![]() Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | President | |
VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member | |
SPARK Venture Management Ltd.
![]() SPARK Venture Management Ltd. Investment ManagersFinance SPARK Venture Management Ltd. (SPARK Ventures) is a venture capital subsidiary of Querist Ltd. founded in 1989 by Kiko Duffy and Thomas Alfred Teichman. The firm is headquartered in London, United Kingdom. | Investment Managers | Head-Equity Investments | |
RIEMSER Pharma GmbH
![]() RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Cita SA | Chief Executive Officer | ||
Pestalozzi Lachenal Patry
![]() Pestalozzi Lachenal Patry Miscellaneous Commercial ServicesCommercial Services Pestalozzi Lachenal Patry is a Swiss company that provides legal services. The private company is based in Zurich, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
INSEAD | College/University | Masters Business Admin | |
University of Gottingen | College/University | Doctorate Degree | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Graduate Degree | |
Université Paris Dauphine-PSL | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree | |
École Centrale Paris | College/University | Undergraduate Degree Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Masters Business Admin | |
Mentha & Associés
![]() Mentha & Associés Miscellaneous Commercial ServicesCommercial Services Mentha & Associés provides legal services. Its areas of activities include banking and finance law, real estate and construction law, financial and estate planning and immigration law. The company was founded in 1955 and is headquartered in Geneva, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vivostat A/S
![]() Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Medical Specialties | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
![]() BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Investor | |
Siparex XAnge Venture SAS
![]() Siparex XAnge Venture SAS Investment ManagersFinance Siparex XAnge Venture SAS is an Independent Venture Capital firm founded in 1977 by Benjamin Teszner. Siparex XAnge Venture SAS is headquartered in Paris. | Investment Managers | Private Equity Investor Private Equity Investor | |
Fertin Pharma A/S
![]() Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Food: Specialty/Candy | Chairman | |
American Chamber of Commerce in Germany eV
![]() American Chamber of Commerce in Germany eV Miscellaneous Commercial ServicesCommercial Services American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
SuppreMol GmbH
![]() SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
CM&D Pharma Ltd.
![]() CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Pharmaceuticals: Major | Founder Chairman | |
Ajinomoto Cambrooke, Inc.
![]() Ajinomoto Cambrooke, Inc. Pharmaceuticals: OtherHealth Technology Ajinomoto Cambrooke, Inc. operates as a therapeutic nutrition company. It offers Glytactin with GMP to help meet the nutritional needs of patients with Phenylketonuria; Tylactin with GMP to help meet the nutritional needs of patients with Tyrosinemia; amino acid formulas for the dietary management of disorders of amino acid metabolism; low protein food; KetoVie, ketogenic formulas for the dietary management of intractable epilepsy; and KetoVie Café Food low-carbohydrate ketogenic food for individuals following the spectrum of ketogenic diets. The company was founded by David Paolella and Lynn Paolella in 2000 and is headquartered in Ayer, MA. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Cell Medica Switzerland AG
![]() Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Central Europe GmbH | Corporate Officer/Principal | ||
Pharmathen SA
![]() Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Pharmaceuticals: Major | Chairman | |
Natixis Venture Sélection SA
![]() Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Investment Managers | Director/Board Member Director/Board Member | |
EUSA Pharma SAS
![]() EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Biotechnology | Director/Board Member | |
SENSORION | Pharmaceuticals: Major | Director/Board Member | |
Robert Koch Stiftung eV | Director/Board Member | ||
Swiss Bar Association | Corporate Officer/Principal | ||
Geneva Association of Business Law | Corporate Officer/Principal | ||
Geneva Bar Association | Corporate Officer/Principal | ||
Convatec (Germany) GmbH
![]() Convatec (Germany) GmbH Medical DistributorsDistribution Services Part of Convatec Group Plc, Convatec (Germany) GmbH wholesales pharmaceutical products. The company is based in Munich, Germany. The CEOs of the German company are Clare Jane Bates, Mercedes Armendariz, Tanja Dormels. | Medical Distributors | Corporate Officer/Principal | |
Isatis Capital SA | Investment Managers | Director/Board Member | |
Hi Inov SAS
![]() Hi Inov SAS Investment ManagersFinance Hi Inov SAS (Hi Inov) is the venture capital arm of Dentressangle Initiatives SAS. The firm was founded by Pierre-Henri Dentressangle and Valérie Gombart in 2012. It is headquartered in Paris, France with an additional office in Bavaria, Germany. | Investment Managers | Chief Executive Officer Private Equity Analyst | |
Mint Solutions Holding BV
![]() Mint Solutions Holding BV Electronic Equipment/InstrumentsElectronic Technology Mint Solutions Holding BV develops solutions that facilitates medical institutions to control medication. It is a complete closed loop medication safety suite for hospitals and healthcare institutions. The company was founded by Ívar Helgason and Gauti Reynisson in 2009 and is headquartered in Washington, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
MAAT PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OSE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TargEDys SA
![]() TargEDys SA BiotechnologyHealth Technology TargEDys SA develops microbiome-based solutions for appetite regulation. It provides humanity with easy means of regulating their eating behaviors for the third millennium. The company was founded by Pierre Dechelotte and Gregory Lambert 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Claudio BidCo A/S
![]() Claudio BidCo A/S Financial ConglomeratesFinance Claudio BidCo A/S operates as an investment company with interests in development and manufacturing of medicated chewing gum. The company was founded on November 24, 2016 and is headquartered in Vejle, Denmark. | Financial Conglomerates | Chairman | |
DayTwo Ltd.
![]() DayTwo Ltd. Medical/Nursing ServicesHealth Services DayTwo Ltd. engages in the provision of glycemic control solution. It focuses on personalized nutrition and actionable insights that allow patient to live healthier, and maintain target blood glucose levels. It offers solutions for employers, clinicians, and patients. The company was founded by Marius Nacht, Yuval Ofek, Lihi Segal, and Yair Schindel in 2015 and is headquartered in Adanim, Israel. | Medical/Nursing Services | Director/Board Member | |
Robert Koch Foundation | Director/Board Member | ||
LiMM Therapeutics SA
![]() LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France. | Financial Conglomerates | Director/Board Member Director/Board Member | |
LeadX Capital Partners /FR/ | Investment Managers | Private Equity Investor Private Equity Investor | |
Bristol-Myers Squibb GmbH & Co. KGaA
![]() Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Francia | 23 |
Germania | 11 |
Svizzera | 8 |
Regno Unito | 4 |
Danimarca | 4 |
Settori
Health Technology | 18 |
Finance | 11 |
Consumer Services | 8 |
Commercial Services | 4 |
Electronic Technology | 3 |
Posizioni
Director/Board Member | 137 |
Private Equity Investor | 55 |
Corporate Officer/Principal | 34 |
Chairman | 18 |
Private Equity Analyst | 16 |
Contatti più connessi
- Borsa valori
- Insiders
- Didier Piccino
- Connessioni Società